This study is currently not accepting new patients, but might later
A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- currently not accepting new patients, but might later
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Clovis Oncology, Inc.
- ID
- NCT04042116
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 227 study participants
- Last Updated